Research Article

Identification of an Individualized Prognostic Signature Based on the RWSR Model in Early-Stage Bladder Carcinoma

Table 3

Univariate and multivariate Cox regression analyses of the signature genes and overall survival.

CharactersCh.descriptionUnivariate analysisMultivariate analysis
HR (95% CI for HR) valueHR (95% CI for HR) value

GEO
 SexFemale/male1.43 (0.76-2.7)2.58-011.13 (0.82-1.55)3.92-02
 Age>70/<=701.15 (1.02-1.14)9.03-031.17 (1.06-1.59)2.91-02
 InvasivenessYes/no2.32 (1.46-3.92)1.64-031.35 (0.65-2.83)4.23-02
 Intravesical therapyYes/no0.67 (0.48-0.93)1.59-020.91 (0.66-1.25)4.57-01
 Stage0-III1.79 (1.37-2.23)2.23-041.39 (1.05-1.86)2.38-03
 GradeLow/high2.76 (1.68-4.57)1.97-031.21 (0.91-1.62)3.93-02
 EventYes/no0.92 (0.51-1.6)7.76-010.46 (0.37-1.99)1.79-02
 Specific survivalAlive/dead13.02 (7.54-24)6.62-0411.79 (10.94-17.38)2.32-03
 Risk scoreLow/high4.45 (4.32-5.32)3.15-074.02 (4.99-8.04)2.46-04
TCGA
 SexFemale/male1.12 (0.73-1.68)7.04-032.95 (0.72-12.04)1.355-02
 Age>70/<=701.36 (0.76-2.35)3.77-021.22 (0.53-2.79)6.42-02
 Height>170/≤170 cm1.24 (0.99-2.5)2.43-031.09 (1.03-1.16)4.43-03
 Weight>80/≤800.99 (0.98-1.07)1.49-020.97 (0.93-1.05)2.97-02
 Diagnosis ageYes/no0.62 (0.33-1.89)4.16-020.83 (0.36-1.90)6.64-02
 StageII/III1.62 (1.3-2.11)2.31-051.5 (0.92-2.58)9.92-04
 GradeHigh/low4.75 (3.63-7.91)9.92-023.8 (2.88-8.34)1.87-01
 Noninvasive historyYes/no0.81 (0.63-1.87)1.04-020.83 (0.43-1.57)5.68-02
 SmokingNo/<15 yr/>15 yr1.41 (1.12-1.85)7.47-031.20 (0.67-2.15)5.53-03
 Risk scoreHigh/low3.93 (3.34-6.35)3.57-063.11 (3.09-4.24)8.42-04